Anil Gulati is a Neurology physician affiliated with Midwestern University. OpenAlex indexes 375 publications with 6,820 citations (h-index 40); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2850 S Wabash Ave
Suite 102
Chicago, IL 606162955
Telephone
312-496-3488Registry record last updated 11 Feb 2016.
Clinical trials
- Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
Sponsor: Pharmazz, Inc.
- PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock
Sponsor: Pharmazz, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- Celgene CorporationProgram year20252 payments
- E.R. Squibb & Sons, L.L.C.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
83.1%Gabapentinoids18.2%Gabapentin74%Pregabalin26%Part D≥110 patientsSSRI12%Trazodone Hcl85%Paroxetine Hcl15%Part D≥83 patients+ 20 more classes in this area
Musculoskeletal
5.3%gamma-Aminobutyric Acid-ergic Agonist5.3%Baclofen100%Part D≥41 patientsMetabolism & gastrointestinal
5.1%Antidiarrheal microorganisms2.9%Folic Acid100%Part D≥22 patientsCorticosteroid1%Prednisone100%Part D≥11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1992–1993 per NIH RePORTER. The latest:
- PERMEABILITY OF MORPHINE ACROSS BBB DURING DEVELOPMENT
University of Illinois at Chicago
FY1993R03DA007112 - PERMEABILITY OF MORPHINE ACROSS BBB DURING DEVELOPMENT
University of Illinois at Chicago
FY1992R03DA007112
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Advances in Therapies to Treat Neonatal Hypoxic-Ischemic Encephalopathy
Journal of Clinical Medicine
2023 - Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury
Antimicrobial Agents and Chemotherapy
2019 - Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model
Journal of Antimicrobial Chemotherapy
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Jason Barr, DO
Midwestern University
James Kinn, MD
Midwestern University
Robert Fintelmann, MD
Midwestern University
Victor Zach, MD
Midwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”